Barely Significant

Excerpts

514,629 sentences

a positive trendp < 0.010.2× alphagold
Considering Mallomonas annulata , negative growth could be detected at 5°C (−0.213 day −1 ) followed by a positive trend from 8°C (0.059 day −1 , p < 0.01) to 11°C (0.386 day −1 , p < 0.01) and to 15°C (0.508 day −1 , p < 0.01) before slightly but not significantly ( p = 0.997) decreasing at 19°C (0.485 day −1 ) and 23°C (0.443 day −1 , p = 0.244).
Cool and Shady: Ecophysiological Preferences of Chrysophytes.
J Eukaryot Microbiol · 2026 · PMC12966406
Inhibition The hierarchical regression analysis showed that, under the more stringent alpha level of 0.01, the association between parent ratings of total motor skills and inhibition among Taiwanese children with ASD did not reach statistical significance after controlling for covariates ( β = 0.26, p = 0.01).
highly significantp < 0.010.2× alphaqualifiedgold
Serum ELISA showed significantly elevated IL-1β, IL-6, and TNF-α and reduced IL-10 in the PC group ( p < 0.01), while the PC+SF group demonstrated highly significant downregulation of pro-inflammatory cytokines and upregulated IL-10 ( p < 0.01), with levels comparable to NC by days 6 and 10 ( p > 0.05).
nominally significantP = 0.010.2× alphagold
Interestingly, a recent analysis of WES data from the UK Biobank ( 43 ) identified a nominally significant gene-based association ( P = 0.01, sequence kernel association test [SKAT]) for THBS1 rare coding variants and POAG (ICD-10 diagnosis code H40), suggesting that further study of rare THBS1 -coding variants in adult-onset POAG might be of interest.
highly significantp < 0.010.2× alphaqualifiedgold
The heterogeneity was substantial ( I 2 = 84.9%), with a highly significant test for heterogeneity ( p < 0.01), indicating considerable variability in the effect sizes across the different studies and elucidating the importance of continuing to perform clinical trials that target CKD and ESKD patients, under similar circumstances.
highly significantP < 0.010.2× alphaqualifiedgold
Both the subjective symptoms (burning and itching) and the objective symptoms (erythema, oedema, exudation) showed a marked reduction as early as the third day of treatment and the comparison between the score at the start of treatment and on day three of the treatment was highly significant in both study groups ( P < 0.01).